Peer Review reports
From: AVAiLABLE NIS – AVASTIN® in lung cancer treatment in routine oncology practice in Germany
Original Submission | ||
---|---|---|
3 Aug 2018 | Submitted | Original manuscript |
31 Oct 2018 | Reviewed | Reviewer Report - Anne-Marie Ruppert |
10 Jan 2019 | Reviewed | Reviewer Report - Reviewer 2 |
16 Feb 2019 | Author responded | Author comments - Mark-Oliver Zahn |
Resubmission - Version 2 | ||
16 Feb 2019 | Submitted | Manuscript version 2 |
28 Feb 2019 | Reviewed | Reviewer Report - Reviewer 2 |
15 Mar 2019 | Reviewed | Reviewer Report - Anne-Marie Ruppert |
4 Apr 2019 | Author responded | Author comments - Mark-Oliver Zahn |
Resubmission - Version 3 | ||
4 Apr 2019 | Submitted | Manuscript version 3 |
12 Apr 2019 | Author responded | Author comments - Mark-Oliver Zahn |
Resubmission - Version 4 | ||
12 Apr 2019 | Submitted | Manuscript version 4 |
Publishing | ||
15 Apr 2019 | Editorially accepted | |
10 May 2019 | Article published | 10.1186/s12885-019-5618-0 |
You can find further information about peer review here.